Actualités 17.04.2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
성공 사례 14.05.2024 BeiGene이 전 세계 암 치료 접근성을 향상하는 방법 BeiGene은 스위스 바젤에 있는 유럽 본사에서 종양학 연구 및 개발을 발전시키고자 전 세계의 이해관계자와 전략적으로 협력합니다. 40개국에 제품을 시판하고 있으며 45개국 이상에서 임상시험을 ...
News 13.05.2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News 06.05.2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
ニュース 12.09.2023 PROVENANCE PROOFがブロックチェーン技術で宝石業界に革命をもたらします 宝石のトレーサビリティを向上させるため、ルツェルンに本拠地を置く企業がProvenance Proof AGブロックチェーンソリューションを開発しました。インタビューでは、クレメンス・リンク取締役が、この革新的なソリューションの成り立ちと利点について語ります。
News 14.02.2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 19.10.2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
뉴스 12.09.2023 PROVENANCE PROOF, BLOCKCHAIN 기술로 보석 산업에 혁신을 일으키다 보석 원산지 추적 관리를 위해 루체른에 소재한 Provenance Proof AG는 블록체인 솔루션을 개발했습니다. 인터뷰에서 클레멘스 링크(Klemens Link) 디렉터는 이 혁신적인 솔루션의 출현과 이점에 대해 이야기합니다.
News 10.01.2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Novità 12.09.2023 PROVENANCE PROOF RIVOLUZIONA L’INDUSTRIA DELLE PIETRE PREZIOSE CON LA TECNOLOGIA BLOCKCHAIN Con l’obiettivo di rendere possibile la tracciabilità delle pietre preziose, l’azienda lucernese Provenance Proof SA ha sviluppato una soluzione ...
Actualités 12.09.2023 PROVENANCE PROOF RÉVOLUTIONNE L’INDUSTRIE DES PIERRES PRÉCIEUSES GRÂCE À LA TECHNOLOGIE BLOCKCHAIN Afin de permettre la traçabilité des pierres précieuses, l’entreprise lucernoise Provenance Proof AG a développé une solution blockchain. Dans un...
Actualités 05.09.2023 Neurosoft innove avec sa technologie pionnière d’interface cérébrale Basée au Campus Biotech à Genève, Neurosoft Bioelectronics a réalisé avec succès un essai clinique révolutionnaire de sa grille d'électrodes exte...
成功故事 25.04.2024 BeiGene如何推动癌症治疗普惠全球 在位于瑞士巴塞尔的欧洲总部,BeiGene 与世界各地的利益相关者进行战略合作,推进肿瘤学的研究和发展。它 在40个国家开展商业运营,并在超过45个国家开展临床试验。 Sirpa Tsimal与BeiGene的Gerwin Winter和Jan-Henrik Terwey讨论了 公司的全球...
News 04.12.2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
Aktuell 12.09.2023 Provenance Proof revolutioniert die Edelsteinindustrie mit Blockchain-Technologie Mit dem Ziel, die Rückverfolgbarkeit von Edelsteinen zu ermöglichen, hat das Luzerner Unternehmen Provenance Proof AG eine Blockchain-L...
News 14.11.2023 Opening of the Dynamic Imaging Center at sitem-insel in Bern sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...